It supports beauty-from-within care, skin radiance, and antioxidant protection when used consistently
In contrast, those using Tirzepatide achieved higher monthly weight loss percentages: approximately 5.9% after 3 months, 10.1% after 6 months, and 15.3% after 12 months, surpassing the weight loss observed with semaglutide
Diabetes Metab 38(1):8688 Hogan AE et al (2011) Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis
This dual action not only suppresses appetite and reduces calorie intake but also improves glucose control and energy utilization more effectively than medications that target only one of these pathways
Intervenciones no farmacolgicas: Ciruga baritrica: Para pacientes con IMC 40 kg/m o 35 kg/m con comorbilidades significativas, los procedimientos baritricos (bypass gstrico en Y de Roux, gastrectoma en manga) ofrecen la prdida de peso ms sustancial y duradera (25-35% del peso corporal inicial) con mejoras significativas en diabetes tipo 2, hipertensin y apnea del sueo
